The world's food supply will become safer as the food industry shifts to high-resolution, whole-genome sequencing - which examines the full DNA of a given organism all at once. This move to make sequencing ubiquitous will lead to the consistently reliable detection of salmonella. A paper pu ... more
Listeria protein provides a CRISPR 'kill switch'
The protein AcrVIA1 instantly stopped the CRISPR editing process
A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA.
The protein, called AcrVIA1, can halt the CRISPR-Cas13 editing process, according to new research from Cornell, Rockefeller University and the Memorial Sloan Kettering Cancer Center published in the journal Science.
"We're expanding our scientific toolbox to effectively use a CRISPR without causing side effects," said co-author Martin Wiedmann, Ph.D. '97, the Gellert Family Professor in Food Safety and director of Cornell's Food Safety Laboratory and Milk Quality Improvement Program. "Thanks to this bacterium, we're getting a chance to turn off and on our ability to make changes to RNA."
CRISPR, or the clustered regularly interspaced short palindromic repeats, is a laboratory mechanism that can act like microscopic scissors and precisely edit the genes contained in DNA. Among the half-dozen types of CRISPRs in use today, CRISPR-Cas13 can edit RNA, which until now had lacked a brake in the editing process.
Since SARS-CoV-2, the coronavirus that causes the COVID-19 disease, is an RNA virus, this new editing accessory may be useful to coronavirus researchers, the scientists said.
Lead author Alex Meeske, postdoctoral researcher in the lab of senior author Luciano Marraffini, professor at Rockefeller University, had suspected that a protein (bacteriophage) housed in Listeria could be useful for RNA editing.
At the start of this study, Meeske reached out to Wiedmann, a food safety expert, to obtain genetic bacterial samples from his food pathogen collection. Doctoral candidate in the Wiedmann laboratory Jingqiu Liao narrowed down the prospects from about 1,500 bacterial candidates to 62 strains.
The Wiedmann lab transferred those samples to Rockefeller, where intern Alice Cassel sequenced the 62 strains and isolated 20 candidate proteins.
One strain stood out: Listeria seeligeri, a harmless bacteria found everywhere in the soil. Unlike its fierce cousin - the foodborne pathogen L. monocytogenes - it does not cause human disease.
The Rockefeller scientists found that the protein AcrVIA1 - derived from L. seeligeri - instantly stopped the CRISPR editing process. "AcrVIA1 can be very useful in controlling application of Cas13. Anything that the Cas13 edits, this anti-CRISPR protein can shut off," Meeske said. "It's a 'kill switch' you can use during the CRISPR editing process, and it has become an additional tool we have at our disposal."
Wiedmann explained that scientists can now work on RNA problems with more exacting means. "This tool gives us more precision," he said.
- food safety
- RNA editing
Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi, according to a new study from Weill Cornell Medicine scientists. Defects in the fungus-fighting abilities of these cells may contribute to some cases of Crohn's disease and ot ... more
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more
- 1analytica 2020: World’s leading trade fair to be held virtually
- 2analytica 2020: The world’s leading trade fair extends its reach with analytica virtual
- 3Portable, point-of-care COVID-19 test could bypass the lab
- 4Researchers dramatically downsize technology for fingerprinting drugs and other chemicals
- 5Attacking tumours directly on identification
- 6Towards a cell-based interceptive medicine in Europe
- 7Giant nanomachine aids the immune system
- 8A tiny instrument to measure the faintest magnetic fields
- 9Leap forward in the fight against antibiotic resistance
- 10New device can measure toxic lead within minutes
- Blood-based test accurately identifies viral infection before symptoms develop
- Method to safely study COVID-19, other contagious diseases developed
- QIAGEN fully acquires NeuMoDx Molecular
- Bruker Announces Acquisition of Canopy Biosciences, LLC
- Portable, point-of-care COVID-19 test could bypass the lab